Cargando…
Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications
Osteosarcoma is a primary malignant tumor that tends to threaten children and adolescents, and the 5-year event-free survival rate has not improved significantly in the past three decades, bringing grief and economic burden to patients and society. To date, the genetic background and oncogenesis mec...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198725/ https://www.ncbi.nlm.nih.gov/pubmed/35720360 http://dx.doi.org/10.3389/fimmu.2022.907550 |
_version_ | 1784727690200219648 |
---|---|
author | Zhu, Tianyi Han, Jing Yang, Liu Cai, Zhengdong Sun, Wei Hua, Yingqi Xu, Jing |
author_facet | Zhu, Tianyi Han, Jing Yang, Liu Cai, Zhengdong Sun, Wei Hua, Yingqi Xu, Jing |
author_sort | Zhu, Tianyi |
collection | PubMed |
description | Osteosarcoma is a primary malignant tumor that tends to threaten children and adolescents, and the 5-year event-free survival rate has not improved significantly in the past three decades, bringing grief and economic burden to patients and society. To date, the genetic background and oncogenesis mechanisms of osteosarcoma remain unclear, impeding further research. The tumor immune microenvironment has become a recent research hot spot, providing novel but valuable insight into tumor heterogeneity and multifaceted mechanisms of tumor progression and metastasis. However, the immune microenvironment in osteosarcoma has been vigorously discussed, and the landscape of immune and non-immune component infiltration has been intensively investigated. Here, we summarize the current knowledge of the classification, features, and functions of the main infiltrating cells, complement system, and exosomes in the osteosarcoma immune microenvironment. In each section, we also highlight the complex crosstalk network among them and the corresponding potential therapeutic strategies and clinical applications to deepen our understanding of osteosarcoma and provide a reference for imminent effective therapies with reduced adverse effects. |
format | Online Article Text |
id | pubmed-9198725 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91987252022-06-16 Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications Zhu, Tianyi Han, Jing Yang, Liu Cai, Zhengdong Sun, Wei Hua, Yingqi Xu, Jing Front Immunol Immunology Osteosarcoma is a primary malignant tumor that tends to threaten children and adolescents, and the 5-year event-free survival rate has not improved significantly in the past three decades, bringing grief and economic burden to patients and society. To date, the genetic background and oncogenesis mechanisms of osteosarcoma remain unclear, impeding further research. The tumor immune microenvironment has become a recent research hot spot, providing novel but valuable insight into tumor heterogeneity and multifaceted mechanisms of tumor progression and metastasis. However, the immune microenvironment in osteosarcoma has been vigorously discussed, and the landscape of immune and non-immune component infiltration has been intensively investigated. Here, we summarize the current knowledge of the classification, features, and functions of the main infiltrating cells, complement system, and exosomes in the osteosarcoma immune microenvironment. In each section, we also highlight the complex crosstalk network among them and the corresponding potential therapeutic strategies and clinical applications to deepen our understanding of osteosarcoma and provide a reference for imminent effective therapies with reduced adverse effects. Frontiers Media S.A. 2022-06-01 /pmc/articles/PMC9198725/ /pubmed/35720360 http://dx.doi.org/10.3389/fimmu.2022.907550 Text en Copyright © 2022 Zhu, Han, Yang, Cai, Sun, Hua and Xu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Zhu, Tianyi Han, Jing Yang, Liu Cai, Zhengdong Sun, Wei Hua, Yingqi Xu, Jing Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications |
title | Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications |
title_full | Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications |
title_fullStr | Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications |
title_full_unstemmed | Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications |
title_short | Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications |
title_sort | immune microenvironment in osteosarcoma: components, therapeutic strategies and clinical applications |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198725/ https://www.ncbi.nlm.nih.gov/pubmed/35720360 http://dx.doi.org/10.3389/fimmu.2022.907550 |
work_keys_str_mv | AT zhutianyi immunemicroenvironmentinosteosarcomacomponentstherapeuticstrategiesandclinicalapplications AT hanjing immunemicroenvironmentinosteosarcomacomponentstherapeuticstrategiesandclinicalapplications AT yangliu immunemicroenvironmentinosteosarcomacomponentstherapeuticstrategiesandclinicalapplications AT caizhengdong immunemicroenvironmentinosteosarcomacomponentstherapeuticstrategiesandclinicalapplications AT sunwei immunemicroenvironmentinosteosarcomacomponentstherapeuticstrategiesandclinicalapplications AT huayingqi immunemicroenvironmentinosteosarcomacomponentstherapeuticstrategiesandclinicalapplications AT xujing immunemicroenvironmentinosteosarcomacomponentstherapeuticstrategiesandclinicalapplications |